68 related articles for article (PubMed ID: 38373993)
1. ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma.
Zhang L; Zheng Y; Chien W; Ziman B; Billet S; Koeffler HP; Lin DC; Bhowmick NA
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001638
[TBL] [Abstract][Full Text] [Related]
2. The role of FoxM1 in immune cells.
Zheng J; Bu X; Wei X; Ma X; Zhao P
Clin Exp Med; 2023 Oct; 23(6):1973-1979. PubMed ID: 36913035
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.
Ziman B; Yang Q; Zheng Y; Sheth M; Nam C; Zhao H; Zhang L; Hu B; Bhowmick NA; Sinha UK; Lin DC
Cell Death Dis; 2024 Feb; 15(2):152. PubMed ID: 38373993
[TBL] [Abstract][Full Text] [Related]
4. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.
Chen X; Chen J; Yu X; Lin G; Chen T
DNA Cell Biol; 2022 Jul; 41(7):671-682. PubMed ID: 35639418
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the master regulator FOXM1 in cancer.
Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
[TBL] [Abstract][Full Text] [Related]
7. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
[TBL] [Abstract][Full Text] [Related]
8. Immune determinants of Barrett's progression to esophageal adenocarcinoma.
Lagisetty KH; McEwen DP; Nancarrow DJ; Schiebel JG; Ferrer-Torres D; Ray D; Frankel TL; Lin J; Chang AC; Kresty LA; Beer DG
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33290281
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation.
Zheng Y; Ziman B; Ho AS; Sinha UK; Xu LY; Li EM; Koeffler HP; Berman BP; Lin DC
Genome Biol; 2023 Aug; 24(1):193. PubMed ID: 37620896
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Shah MA; Kennedy EB; Alarcon-Rozas AE; Alcindor T; Bartley AN; Malowany AB; Bhadkamkar NA; Deighton DC; Janjigian Y; Karippot A; Khan U; King DA; Klute K; Lacy J; Lee JJ; Mehta R; Mukherjee S; Nagarajan A; Park H; Saeed A; Semrad TJ; Shitara K; Smyth E; Uboha NV; Vincelli M; Wainberg Z; Rajdev L
J Clin Oncol; 2023 Mar; 41(7):1470-1491. PubMed ID: 36603169
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer.
Tang Q; Liu C; Zhang S; He L; Liu Y; Wang J; Zhao X; Li X
Neoplasia; 2023 Feb; 36():100863. PubMed ID: 36528911
[TBL] [Abstract][Full Text] [Related]
12. Generation and multiomic profiling of a
Zhao H; Cheng Y; Kalra A; Ma K; Zheng Y; Ziman B; Tressler C; Glunde K; Shin EJ; Ngamruengphong S; Khashab M; Singh V; Anders RA; Jit S; Wyhs N; Chen W; Li X; Lin DC; Meltzer SJ
Sci Transl Med; 2022 Nov; 14(673):eabq6146. PubMed ID: 36449602
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.
Madhi H; Lee JS; Choi YE; Li Y; Kim MH; Choi Y; Goh SH
Adv Sci (Weinh); 2022 Oct; 9(29):e2202702. PubMed ID: 35975458
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
